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In memoriam of Professor Siegfried Hünig.
Leontidine and camoensine, the main representatives of the
small quinolizidine-indolizidine alkaloid subgroup, are charac-
terized by an inner bispidine system to which a 2-pyridone and
a pyrrolidine are fused on opposite sides. We efficiently
synthesized both natural products from the commercially
available and abundant alkaloid cytisine, which was converted
into the key intermediate, N-Boc-11-oxocytisine, by iodine
oxidation and protection. Grignard addition, Paal-Knorr type
cyclization, and hydrogenation delivered endo-pyrrolidine fused
leontidine, while the reversed reaction order, viz. reduction,
Sakurai allylation, and ring closure, afforded exo-pyrrolidine
annulated camoensine. Hydrogenation and deoxygenation of
the pyridone moieties provided four further alkaloids, tetrahy-
droleontidine, camoensidine, 11-epileontidane and leontidane.
In addition, the artificial alkaloid isoleontidine, carrying an endo-
fused pyrrolidine on the same side as the pyridone, was
prepared from C-13 oxidized cytisine.
Introduction
Tri- and tetracyclic (bis)quinolizidine alkaloids (Figure 1) are the
most prominent secondary metabolites in the Papilionoideae
subfamily of the plant family Fabaceae (Leguminosae).[1,2] These
natural products are all structurally characterized by an inner
bispidine core (3,7-diazabicyclo[3.3.1]nonane, 6), to which
normally combinations of an exo- or endo-piperidine, as in
sparteine (1), lupanine (2), anagyrine (4), and thermopsine (5),
or an oxidized version thereof, such as the 2-piperidone in 2 or
the 2-pyridone in cytisine (3), 4, and 5, are attached on opposite
sides. This structural feature is a consequence of their biosyn-
thesis from three molecules of l-lysine (C5N source): two of
them form the outer piperidines while the third one completes
the central bispidine core (see arrangement A, n=1).[1,3] The
initially produced metabolites are sparteine (1) and lupanine
(2), which get further modified, for example by oxidation,
degradation, and epimerization, thus setting the basis for the
roughly 200 known (bis)quinolizidine alkaloids.
In addition to the ‘standard’ (bis)quinolizidine alkaloids, a
small number of atypical quinolizidine-indolizidine derivatives
(7–12) exists that possess an exo- or endo-fused pyrrolidine.[4] It
is hypothesized that the smaller ring size results from a
replacement of one molecule of l-lysine by l-ornithine (C4N
source) during their biosynthesis.[5] The first member of this
subclass, leontidine (7), was already isolated in 1932 from
Leontice ewersmannii,[6] camoensine (10)[7] and camoensidine
(11),[8] both first extracted from Camoensia maxima, followed in
1975. Tetrahydroleontidine (8)[8d] and 11-epileontidane (12)[8d]
were detected by GC-MS in Maackia amurensis, their only
natural source so far. The fully reduced derivative in the
leontidine row, leontidane (12), has not yet been found in
nature.
The first syntheses of these alkaloids were done in the
context of their (stereo)structure elucidation. Santamaria and
Khuong-Huu prepared camoensidine (11) from lupanine (2) by
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Figure 1. Natural (bis)quinolizidine alkaloids (1–5), the inner bispidine core 6,
and the rare quinolizidine-indolizidine alkaloids (7–12).
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formal ring contraction (4 steps, 7% yield),[6g] while Yunusov’s
route from cytisine (3) to leontidine (7) included an unintended
epimerization (4 steps, 0.4% yield).[6e,g] The synthesis of
camoensine (10) by Ohmiya and coworkers is illustrated in
Scheme 1 (bottom).[10] Chlorination of cytisine (3) followed by
HCl elimination furnished the imine 16 in low 40% yield
because of regioselectivity issues.[11] Addition of the Grignard
reagent 17 occurred highly diastereoselectively to the less
hindered exo-face of 16, but in low 23% yield, thus giving, after
acetal hydrolysis and reductive cyclization, the alkaloid 10 in
overall 4 steps and meager 8% yield. Furthermore, exo-
configured camoensine (10) and camoensidine (11) were trans-
formed into their endo-counterparts, leontidine (7) and tetrahy-
droleontidine (8), by an oxidation-reduction sequence, but
again in low yields (9–11%).[6g] Satisfying yields (>80%) were
solely obtained in the hydrogenations of the pyridone deriva-
tives 7 and 10 to the respective piperidones 8 and 11.[6g]
We recently presented an effective inside-out approach to
tri- and tetracyclic bisquinolizidine alkaloids that permits access
to more than 25 members of this class in both enantiomeric
forms (Scheme 1, top).[12–14] Key sequences include the reductive
desymmetrization of the bisimide 13 and the transformation of
the resulting dioxobispidine 14 into the α,N-pyridone annulated
tricycle 15. An important stereochemical feature is that the N-
Boc activated lactam function in 15 allows an introduction of
either an endo- or, optionally, an exo-fused ring by a simple
change of the reaction order. Since all nucleophilic attacks on
the carbonyl group in 15 or on related functionalities occur
highly selectively from the less hindered, convex exo-face, a
reduction-organyl addition sequence will install an exo-substitu-
ent (exo-protocol), while the reversed organyl addition-reduc-
tion procedure will generate an endo one (endo-protocol).
Given the ease of stereoselective ring annulation at 15, we
decided to develop the first efficient and diastereodivergent
route to the quinolizidine-indolizidine alkaloids 7–12 of the
leontidine/camoensine family. Although key intermediate 15
can be prepared from 13 by total synthesis,[12] we searched for a
straightforward ex-natural-pool approach. The abundant, com-
mercially available alkaloid cytisine (3), which can be isolated in
good quantities from the seeds of the Golden Rain tree,
Laburnum anagyroides,[15] seemed to be an ideal source.
Results and Discussion
Our synthesis commenced with the search for a suitable
method that permits an oxidation of the amino function in
cytisine (3) to an amide. Screening of several reagents (e.g.
K3Fe(CN)6, PhI(OAc)2, KMnO4) and optimization of the reaction
conditions revealed iodine as oxidant of choice,[16] which is also
advantageous with regard to environmental aspects. Treatment
of 3 with an excess of iodine (7.5 equivalents) in THF/sat.
NaHCO3 (1 : 1) at 70 °C delivered a 2 :1 mixture of desired 11-
oxocytisine (18), a natural product by itself,[17] and the
unwanted C-13 oxidation product 19 (Scheme 2). Thus, the
effect of the fused pyridone on the regioselectivity of the
oxidation step is just small,[18] which is in good agreement with
the results of earlier NCS oxidations of 3 (see Scheme 1).[11]
Since chromatographic separation of the isomers 18 and 19
proved to be tedious, the crude reaction mixture was subjected
to N-Boc protection, which provided, after column chromatog-
raphy or, even more conveniently, after MPLC separation, the
key intermediate 15 in analytically pure form and overall 50%.
The N-Boc lactam 20 was obtained in 25% yield.
The leontidine-type natural products were accessed from 15
by applying the endo-protocol (Scheme 3). Addition of the
functionalized Grignard reagent 17 occurred smoothly at the N-
Boc imide function and delivered, after ring opening of the
primarily resulting hemiaminal during work up, the ketone 21
in high 82% yield. The N-Boc group was cleaved under Lewis
acidic conditions, which triggered a Paal-Knorr type intra-
molecular pyrrole synthesis that afforded the unnatural pyrrolo-
cytisine 22[19,20] in a single step and 75% yield. Preferential
hydrogenation of the electron-rich pyrrole in the presence of
the pyridone was achieved with PtO2 under acidic conditions
and a short reaction time. Other catalysts, such as Pd/C,
Pd(OH)2/C, Pd(OAc)2, Ru/C, RhCl(PPh3)3, or Raney-Ni, afforded
mixtures of 7 and 8. As expected, hydrogenation exclusively
occurred from the less concave exo-site and solely provided
natural, endo-pyrrolidine fused leontidine (7). Under the same
Scheme 1. Known[10,12,13] and current strategies for the total synthesis of
bisquinolizidine and quinolizidine-indolizidine alkaloids.
Scheme 2. Preparation of the key intermediate 15 by oxidation of cytisine
(3) and N-Boc protection.
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conditions, but at prolonged reaction times, the pyridone
moieties in 22 and 7 were hydrogenated, too, giving the
alkaloid tetrahydroleontidine (8) as the only product and in
high �90% yield. Final reduction of 8 with LiAlH4 afforded
leontidane (9), an alkaloid which has not yet been found in
nature.
Submission of the C-13 oxidized cytisine derivative 20 to
the addition-cyclization sequence described above delivered
the tetracyclic pyrrolo alkaloid 23 (Scheme 4).[21] Mild hydro-
genation afforded the artificial alkaloid isoleontidine (24), a
regioisomer of leontidine (7) with both fused rings on the same
side, in 33% overall yield over three steps.
The members of the camoensine family, 10–12, were
synthesized by using the exo-protocol, which is based on a
reduction-addition sequence (Scheme 5). Reduction of the
lactam 15 and acetalization, as developed earlier in our
group,[12] provided the N,O-acetal 25 in high 91% yield. All
attempts to introduce functionalized lithium, magnesium, zinc,
and copper organyls (e.g. 17) to 25 or the iminium species
derived thereof were met with low success,[22] which parallels
the insufficient yields reached by Ohmiya et al. in their additions
to the imine 16 (see Scheme 1).[10] To circumvent this problem,
N,O-acetal 25 was converted into the natural alkaloid 11-
allylcytisine (26),[23,24] following a known Sakurai protocol
(85%).[12] The direct hydroamination of 26 to camoensine (10) in
the presence of a catalytic amount of a RhI-phosphine
complex[25] failed, and one-pot protocols such as hydrozircona-
tion with the Schwartz reagent cp2ZrHCl or hydroboration with
BH3 ·SMe, both followed by a metal/iodine exchange and an
intramolecular substitution to close the pyrrolidine, delivered
10 in just low yields (<20%).[26] By far more efficient was a two-
step sequence: Hydroboration of 26 with 9-BBN and subse-
quent oxidation[27] afforded selectively the terminal alcohol 27,
which was subjected to hydroxy/bromide exchange under
Appel conditions providing, after in-situ ring closure under HBr
elimination, the desired natural product camoensine (10) in
good 68% yield over two steps. Hydrogenation of 10 over PtO2
under acidic conditions delivered camoensidine (11), which was
reduced with LiAlH4 to give the third natural alkaloid in this
row, 11-epileontidane (12).
We finally tested the alkaloids 7–12, 15, 18–22, and 25–27,
on their activity against the cancer lines U87 (glioblastoma),
518A2 (melanoma), and HCT116 (colon cancer), but no notice-
able cytotoxicity (MTT assay, IC50 (72 h) <50 μM) was observed.
Conclusion
We successfully developed an efficient route to the quinolizi-
dine-indolizidine alkaloids 7–12. Key intermediate was N-Boc
activated 11-oxocytisine (15), which was accessed in 50% yield
by iodine oxidation and protection of the commercially
available alkaloid cytisine (3). Grignard addition, Paal-Knorr type
cyclization, exo-hydrogenation, and reduction afforded the
three endo-pyrrolidine annulated alkaloids leontidine (7), tetra-
hydroleontidine (8), and leontidane (9) in a row (3–4 steps, 55–
38% yield). Their exo-pyrrolidine fused counterparts, camoen-
sine (10), camoensidine (11), and 11-epileontidane (12), were
prepared from 15 in 4–6 steps and 53–28% yield by reduction,
exo-selective Sakurai allylation, ring closure, and adjustment of
the oxidation state in the original pyridone moiety. In addition,
the artificial alkaloid isoleontidine 24, a regioisomer of 7 that
carries an 13,N-fused pyrrolidine, was synthesized from the C-13
oxidized cytisine derivative 20.
Scheme 3. Synthesis of the endo-pyrrolidine fused quinolizidine-indolizidine
alkaloids 7–9 of the leontidine family.
Scheme 4. Synthesis of the artificial alkaloid isoleontidine (24).
Scheme 5. Synthesis of the exo-pyrrolidine fused quinolizidine-indolizidine
alkaloids 10–12 of the camoensine family.
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Experimental Section
All reactions with moisture-sensitive reagents were carried out
under argon atmosphere in anhydrous solvents, prepared using
standard procedures.[28] Commercially available reagents (highest
quality available) were used as received. Reactions were monitored
by thin layer chromatography on precoated silica gel (Merck TLC
Silica gel 60 F254). Spots were visualized by UV light (254 nm) or by
staining with aqueous KMnO4, vanillin, or Dragendorff’s reagent.
Silica gel (Macherey-Nagel, particle size 40–63 μm) was used for
column chromatography. Melting points were measured on a
Thermo Scientific 9300 melting point apparatus. Optical rotations
were recorded on a Jasco P-1020 polarimeter (10 cm cell) and are
given in units of degcm3g   1dm   1. NMR spectra were taken on a
Bruker Avance III HD 500 instrument and calibrated using the
residual undeuterated solvent as an internal reference. All signal
assignments in the 1H and 13C NMR data were made on basis of 2D
NMR spectra (COSY, HSQC, HMBC). Infrared spectra were recorded
on a PerkinElmer Spectrum 100 FT-IR spectrometer, high resolution
mass spectra on a ThermoFisher Scientific Q-Exactive (Orbitrap)
mass spectrometer using ESI (electrospray ionization). The alkaloid
cytisine (3), which is also commercially available, was isolated from
the seeds of Laburnum anagyroides following ref. [15]. For reasons
of consistency, all tri- and tetracyclic alkaloids prepared are
numbered following the standard alkaloid numbering (for details,
see Supporting Information).
Oxidation of cytisine (3): Cytisine (3; 2.00 g, 10.5 mmol), dissolved
in THF (300 mL) and H2O (120 mL), was treated with I2 (20.0 g,
78.8 mmol) and NaHCO3 (8.82 g, 105 mmol). After 5 h at 70 °C, the
reaction mixture was cooled to rt, and sat. aq. Na2S2O3 (120 mL) and
sat. aq. Na2CO3 (200 mL) were added. The organic solvent THF was
removed under vacuum and the remaining aqueous layer was
exhaustively extracted with CH2Cl2/MeOH (4 :1, 20×100 mL) and,
after addition of NH3 (aq., 25%, 30 mL), with CH2Cl2 (15×100 mL)
and CHCl3 (5×100 mL). Evaporation of the solvent delivered a 2 :1
mixture of crude 18 and 19 (2.14 g). CH2Cl2 (100 mL) was added
and the slurry was treated with Boc2O (5.73 g, 26.3 mmol), NEt3
(4.37 mL, 3.19 g, 31.5 mmol), and DMAP (128 mg, 1.05 mmol) at rt.
After 19 h, sat. aq. NH4Cl (200 mL) was added and the reaction
mixture was extracted with CH2Cl2 (3×200 mL). The combined
organic layers were dried over Na2SO4, evaporated, and the residue
was purified by MPLC [Grace Reveleris apparatus, SiO2 cartridge
(80 g), CH2Cl2/MeOH 100 :0!80 :20] to give the N-Boc imides 15
and 20 in analytically pure form each. Purification and separation of
15 and 20 by column chromatography (SiO2, CH2Cl2/MeOH 100 :0!
95 :5) is also possible, but more tedious. Analytically pure samples
of 18 and 19 were obtained from the intermediate mixture of 18
and 19 by repeated column chromatography (SiO2, CH2Cl2/MeOH
100 :0!95 :5). 11-Oxocytisine (18): All characterization data were
in full agreement with those reported in ref. [12]. 13-Oxocytisine
(19): Colorless crystals. Rf =0.23 (CH2Cl2/MeOH/NH3 (aq., 25%)
95 :4.5 : 0.5); m.p. 255–260 °C (decomp.); [α]D
28= +138.4 (c =1.0,
MeOH); 1H NMR (CDCl3, 500 MHz): δ=7.26 (m, 1 H, 5-H), 6.63 (s, 1 H,
NH), 6.46 (d, J =9.1 Hz, 1 H, 3-H), 6.24 (d, J =6.8 Hz, 1 H, 4-H), 4.10
(d, J =15.9 Hz, 1 H, 10-HH), 4.02 (dd, J =15.9 Hz, 6.8 Hz, 1 H, 10-HH),
3.67 (dd, J =12.4 Hz, 5.1 Hz, 1 H, 11-HH), 3.57 (s, 1 H, 7-H), 3.36 (d,
J =12.4 Hz, 1 H, 11-HH), 2.78 (s, 1 H, 9-H), 2.22 (dm, J =13.2 Hz, 1 H,
8-HH), 2.10 (dm, J =13.2 Hz, 1 H, 8-HH) ppm; 13C NMR (CDCl3,
125 MHz): δ=169.6 (C-13), 163.5 (C-2), 143.8 (C-6), 139.2 (C-5), 118.5
(C-3), 106.7 (C-4), 49.8 (C-10), 48.5 (C-11), 42.9 (C-7), 24.7 (C-9), 22.9
(C-8) ppm; IR (ATR): ~v =3237, 2925, 1651, 1567, 1544, 1490, 1362,
1146,782 cm  1; HRMS (ESI): m/z calcd for C11H12N2O2+H
+ :
205.09715 [M+H]+; found: 205.09700. N-Boc-11-oxocytisine (15):
Colorless crystals; yield: 1.59 g (5.22 mmol, 50%); Rf =0.35 (CH2Cl2/
MeOH/NH3 (aq., 25%) 95 :4.5 : 0.5). All characterization data were in
full agreement with those reported in ref. [12]. N-Boc-13-oxocyti-
sine (20): Colorless crystals; yield: 785 mg (2.53 mmol, 25%); Rf =
0.54 (CH2Cl2/MeOH 95 :5); m.p. 172–175 °C; [α]D
25=   399.4 (c =1.0,
MeOH); 1H NMR (CDCl3, 500 MHz): δ=7.29 (dd, J =9.0 Hz, 7.0 Hz, 1
H, 4-H), 6.52 (d, J =9.2 Hz, 1 H, 3-H), 6.29 (d, J =6.8 Hz, 1 H, 5-H),
4.22 (d, J =15.7 Hz, 1 H, 10-HH), 3.96 (dd, J =15.7 Hz, 6.4 Hz, 1 H,
10-HH), 3.86 (dd, J =13.3 Hz, 5.7 Hz, 1 H, 11-HH), 3.76 (m, 2 H, 7-H,
11-HH), 2.88 (s, 1 H, 9-H), 2.28 (d, J =13.3 Hz, 1 H, 8-HH), 2.13 (d, J =
13.2 Hz, 1 H, 8-HH), 1.49 (s, 9 H, C(CH3)3) ppm;
13C NMR (CDCl3,
125 MHz): δ=167.9 (C-13), 163.5 (C-2), 152.0 (CO2N), 142.7 (C-6),
139.3 (C-4), 119.0 (C-3), 107.2 (C-5), 84.1 (C(CH3)3), 52.5 (C-11), 49.6
(C-10), 45.8 (C-7), 28.1 (C(CH3)3), 25.8 (C-9), 23.1 (C-8) ppm; IR (ATR):
~v =2985, 1719, 1696, 1650, 1576, 1544, 1367, 1273, 1256, 1136,
790 cm  1; HRMS (ESI): m/z calcd for C16H20N2O4+H
+ : 305.15015 [M
+H]+; found: 305.14828.
(7R,9R)-N-Boc-9-(aminomethyl)-7-(4,4-dimethoxybutanoyl)-
6,7,8,9-tetrahydro-4H-quinolizin-4-one (21): The Grignard reagent
17 was freshly prepared from 3-bromo-1,1-dimethoxypropane
(518 μL, 705 mg, 3.85 mmol), which was added to Mg (85.1 mg,
3.50 mmol) and I2 (catalytic amount) in anhydr. THF (10 mL). The
reaction mixture was refluxed for 60 min and then cooled to rt. This
Grignard reagent was added dropwise at 0 °C to a solution of the
N-Boc imide 15 (366 mg, 1.20 mmol) in THF (11 mL). After 2 h, sat.
aq. NH4Cl (50 mL) was added and the reaction mixture was
successively extracted with CH2Cl2/MeOH (90 :10, 2×50 mL) and
CH2Cl2 (3×50 mL). The combined organic layers were dried over
Na2SO4, evaporated, and the residue was purified by column
chromatography (SiO2, CH2Cl2/MeOH 100 :0!95 :5) to give ketone
21 as a colorless oil; yield: 402 mg (986 μmol, 82%); Rf =0.41
(CH2Cl2/MeOH 95 :5); [α]D
25=   110.7 (c =0.5, MeOH); 1H NMR
(CDCl3, 500 MHz, 9 : 1 mixture of rotamers, *= isolated signal of the
minor rotamer): δ=7.27 (dd, J =9.2 Hz, 6.9 Hz, 1 H, 4-H), 6.46 (d, J =
9.1 Hz, 1 H, 3-H), 6.10 (d, J =6.8 Hz, 1 H, 5-H), 4.83 (m, 0.9 H, NH),
4.66 (m, 0.1 H, NH*), 4.58 (m, 0.1 H, 10-HH*), 4.44 (dd, J =14.4 Hz,
4.8 Hz, 0.9 H, 10-HH), 4.34 (t, J =5.4 Hz, 1 H, CH(OCH3)2), 4.00 (dd,
J =14.3 Hz, 8.7 Hz, 0.9 H, 10-HH), 3.78 (m, 0.1 H, 10-HH*), 3.54 (dt,
J =14.0 Hz, 6.3 Hz, 1 H, NHCHH), 3.31 (s, 3 H, OCH3), 3.29 (s, 3 H,
OCH3), 3.28 (m, 1 H, NHCHH), 3.08 (m, 0.9 H, 7-H), 3.00 (m, 1.1 H, 9-
H, 7-H*), 2.62 (td, J =7.1 Hz, 2.7 Hz, 2 H, COCH2), 2.17 (dt, J =
13.7 Hz, 7.2 Hz, 1 H, 8-HH), 1.90 (m, 2 H, COCH2CH2), 1.77 (dt, J =
13.7 Hz, 8.8 Hz, 1 H, 8-HH), 1.43 (s, 9 H, C(CH3)3) ppm;
13C NMR
(CDCl3, 125 MHz): δ=209.0 (COCH2), 163.1 (C-2), 156.0 (CO2N), 147.6
(C-6), 138.9 (C-4), 117.7 (C-3), 104.3 (C-5), 103.8 (CH(OCH3)2), 80.0
(C(CH3)3), 53.7 (OCH3), 53.4 (OCH3), 45.4 (C-9), 44.0 (NHCH2), 41.2 (C-
10), 38.1 (C-7), 36.1 (COCH2), 28.5 (C(CH3)3), 26.7 (COCH2CH2), 25.3
(C-8) ppm; IR (ATR): ~v =2935, 1707, 1653, 1545, 1366, 1271, 1251,
1165, 1127, 1057, 797, 732 cm  1; HRMS (ESI): m/z calcd for
C21H32N2O6+Na
+ : 431.21526 [M+Na]+; found: 431.21402.
Pyrrolocytisine 22: A solution of ketone 21 (565 mg, 1.39 mmol) in
anhydr. CH2Cl2 (20 mL) was slowly treated with BF3 ·OEt2 (878 μL,
984 mg, 6.93 mmol) at 0 °C. After 1 h at 0 °C and 1 h at rt, MeOH/
NH3 (aq., 25%; 9 :1, 2 mL) was added and stirring was continued for
10 min. The crude reaction mixture was directly subjected to
column chromatography (SiO2, CH2Cl2/MeOH/NH3 (aq., 25%)
99 :0.9 : 0.1!95 :4.5 : 0.5) to give 22 as colorless crystals; yield:
236 mg (1.04 mmol, 75%); Rf =0.42 (CH2Cl2/MeOH 95 :5); m.p. 202–
204 °C {ref. [19]: 225–226 °C}[29]; [α]D25=   120.3 (c =0.5, MeOH)
{ref. [19]: [α]D  113.5 (c =1.5, MeOH)}
[29]. 1H NMR (CDCl3, 500 MHz):
δ=7.27 (dd, J =9.0 Hz, 6.9 Hz, 1 H, 4-H), 6.44 (m, 1 H, 12-H), 6.42
(m, 1 H, 5-H), 6.15 (d, J =6.9 Hz, 1 H, 3-H), 6.12 (t, J =3.1 Hz, 1 H, 14-
H), 5.97 (m, 1 H, 13-H), 4.33 (dm, J =14.5 Hz, 1 H, 10-HH), 4.28 (dd,
J =11.9 Hz, 4.2 Hz, 1 H, 16-HH), 4.10 (dm, J =11.9 Hz, 1 H, 16-HH),
3.75 (dd, J =14.5 Hz, 4.5 Hz, 1 H, 10-HH), 3.69 (m, 1 H, 9-H), 3.44 (m,
1 H, 7-H), 2.21 (dm, J =13.0 Hz, 1 H, 8-HH), 2.16 (dm, J =13.0 Hz, 1
H, 8-HH); 13C NMR (CDCl3, 125 MHz): δ=163.5 (C-2), 149.1 (C-6),
138.8 (C-4), 130.6 (C-11), 118.9 (C-12), 118.1 (C-5), 109.0 (C-14), 106.2
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(C-3), 105.1 (C-13), 53.8 (C-16), 52.6 (C-10), 33.8 (C-7), 27.4 (C-9), 24.5
(C-8); ppm; IR (ATR): ~v =2939, 1651, 1573, 1544, 1345, 1316, 1139,
800, 709 cm  1; HRMS (ESI): m/z calcd for C14H14N2O+H
+ : 227.11789
[M+H]+; found: 227.11717.
General hydrogenation procedure: A mixture of the pyridone (7,
10, 22, or 23) and PtO2 (10 mol%) in AcOH (5 mL/200 μmol
pyridone) was hydrogenated at rt and 1 bar H2 pressure. The
reaction mixture was filtered through a pad of celite and the filter
cake was thoroughly washed with CH2Cl2/MeOH (80 :20, 25 mL/
200 μmol pyridone). After evaporation of the solvent, the crude
product was dissolved in aq. NaOH (20 mL/200 μmol pyridone) and
extracted with CH2Cl2 (5×5 mL/200 μmol pyridone). The organic
layer was dried over Na2SO4 and the solvent was removed in
vacuum. Column chromatography ((deactivated) SiO2, CH2Cl2/
MeOH/NH3 (aq., 25%) 100 :0 :0!95 :4.5 : 0.5) afforded the hydro-
genated product.
Leontidine (7): Following the general hydrogenation procedure,
the pyrrole 22 (98.5 mg, 435 μmol) was hydrogenated for exactly
2.25 h. Work up and chromatography afforded, besides small
amounts of 22 (7%) and 8 (9%), the natural alkaloid leontidine (7)
as colorless crystals; yield: 72.3 mg (314 μmol, 72%); Rf =0.29
(CH2Cl2/MeOH/NH3 (aq., 25%) 95 :4.5 : 0.5); m.p. 120–122 °C {re-
f. [6a, 6b,6c, 6e]: 116–120 °C; ref. [6g]: 145 °C[29]}; [α]D30=   170.5 (c=
1.22, MeOH)[30] {ref. [6b]: [α]D=   188.7 (c=1.7, MeOH); ref. [6c]:
[α]D=   192.2 (c =1.7, MeOH); ref. [6e]: [α]D=   186.5 (c =1.22,
MeOH); ref. [6 g]: [α]D=   180};
1H NMR (CDCl3, 500 MHz):
[31] δ=7.25
(m, 1 H, 4-H), 6.42 (d, J =9.0 Hz, 1 H, 3-H), 5.96 (d, J =6.8 Hz, 1 H, 5-
H), 4.04 (d, J =15.7 Hz, 1 H, 10-HH), 3.73 (dd, J =15.7 Hz, 7.0 Hz, 1 H,
10-HH), 3.06 (d, J =10.3 Hz, 1 H, 16-HH), 2.93 (s, 1 H, 7-H), 2.82 (m, 1
H, 14-HH), 2.37 (m, 1 H, 9-H), 2.33 (dm, J =10.3 Hz, 1 H, 16-HH), 2.12
(m, 1 H, 11-H), 1.99 (m, 2 H, 14-HH, 8-HH), 1.81–1.58 (m, 5 H, 8-HH,
12-H2, 13-H2);
13C NMR (CDCl3, 125 MHz): δ=164.0 (C-2), 152.1 (C-6),
138.7 (C-4), 116.7 (C-3), 104.6 (C-5), 67.9 (C-11), 60.1 (C-16), 53.9 (C-
14), 44.3 (C-10), 35.3 (C-7), 29.6 (C-9), 27.5 (C-8), 26.8 (C-12), 20.9 (C-
13) ppm; IR (ATR): ~v =2935, 2784, 1651, 1570, 1547, 1341, 798 cm  1;
HRMS (ESI): m/z calcd for C14H18N2O+H
+ : 231.14919 [M+H]+;
found: 231.14860.
Tetrahydroleontidine (8) from 7: Following the general hydro-
genation procedure, leontidine (7; 50.0 mg, 217 μmol) was hydro-
genated for 20 h. Work up and chromatography (deactivated SiO2)
delivered the natural alkaloid tetrahydroleontidine (8) as a yellowish
resin which partially crystallized upon standing; yield: 46.3 mg
(198 μmol, 91%); Rf =0.28 (CH2Cl2/MeOH/NH3 (aq., 25%)
95 :4.5 : 0.5); m.p. 60–64 °C {ref. [19]: 62.5–64.5 °C; ref. [6g]: 62–67 °C};
[α]D
26=   44.3 (c=1.0, MeOH) {ref. [19]: [α]D=   45.3 (c =4.4, EtOH);
ref. [6 g]: [α]D=   46};
1H NMR (MeOD, 500 MHz): δ=4.74 (dt, J =
13.9 Hz, 2.0 Hz, 1 H, 10-HH), 3.59 (m, 1 H, 6-H), 3.35 (dt, J =11.4 Hz,
2.0 Hz, 1 H, 16-HH), 2.88 (m, 1 H, 14-HH), 2.71 (dd, J =13.9 Hz,
3.6 Hz, 1 H, 10-HH), 2.32 (m, 1 H, 3-HH), 2.23 (m, 1 H, 3-HH), 2.12
(dd, J =11.4 Hz, 2.5 Hz, 1 H, 16-HH), 2.07 (m, 1 H, 11-H), 1.96 (dm,
J =12.5 Hz, 1 H, 8-HH), 1.91–1.77 (m, 6 H, 4-HH, 5-H2, 8-HH, 9-H, 14-
HH), 1.73 (m, 1 H, 7-H), 1.70–1.58 (m, 5 H, 4-HH, 12-H2, 13-H2);
13C
NMR (MeOD, 125 MHz): δ=171.5 (C-2), 68.6 (C-11), 60.6 (C-6), 55.1
(C-14), 53.9 (C-16), 42.3 (C-10), 35.8 (C-8), 35.4 (C-7), 33.7 (C-3), 32.2
(C-9), 28.5 (C-5), 28.0 (C-12), 21.8 (C-13), 20.7 (C-4) ppm; IR (ATR): ~v =
2932, 2777, 1622, 1547, 1445, 1351, 1256, 1163, 1101 cm  1; HRMS
(ESI): m/z calcd for C14H22N2O+H
+ : 235.18049 [M+H]+; found:
235.18058.
Tetrahydroleontidine (8) from 22: Following the general hydro-
genation procedure, pyrrole 22 (53.6 mg, 237 μmol) was hydro-
genated for 18 h, giving, after work up and chromatography
(deactivated SiO2), tetrahydroleontidine (8) as a colorless resin;
yield: 50.0 mg (213 μmol, 90%). All characterization data were
identical to those given above.
Leontidane (9): Tetrahydroleontidine (8; 30.0 mg, 128 μmol) was
dissolved in anhydr. THF (6 mL) and cooled to 0 °C. LiAlH4 (2.4 M in
THF, 425 μL, 1.02 mmol) was added and the reaction mixture was
refluxed for 19 h. At rt, sat. aq. Na2SO4 (15 mL) was added dropwise
until gas evolution ceased. The aqueous layer was extracted with
Et2O (5×10 mL), and the combined organic layers were dried over
Na2SO4 and concentrated under reduced pressure. The residue was
dissolved in aq. HCl (4 M, 15 mL) and extracted with hexanes
(15 mL) and Et2O (15 mL). The organic layers were discarded. The
aqueous layer was basified (pH=14) with aq. NaOH (6.0 M, 15 mL)
and extracted with Et2O (3×15 mL). The combined organic layers
were dried over Na2SO4 and the solvent was removed under
vacuum to give the alkaloid leontidane (9) as a colorless oil (note:
this compound slowly decomposes upon exposure to air); yield:
19.5 mg (88.5 μmol, 69%); Rf =0.15 (CH2Cl2/MeOH/NH3 (aq., 25%)
90 :9 : 1); [α]D
25= +17.8 (c =0.1, MeOD) {ref. [6c]: [α]D= +16.5 (c=
6.1, EtOH)}; 1H NMR (MeOD, 500 MHz): δ=3.23 (d, J =11.3 Hz, 1 H,
16-HH), 3.04 (m, 1 H, 14-HH), 2.98 (d, J =11.8 Hz, 1 H, 10-HH), 2.78
(d, J =10.7 Hz, 1 H, 2-HH), 2.20 (d, J =11.9 Hz, 1 H, 10-HH), 2.13 (m,
2 H, 11-H, 16-HH), 2.05 (d, J =11.3 Hz, 1 H, 6-H), 1.88–1.73 (m, 7 H,
2-HH, 3-HH, 5-HH, 8-HH, 9-H, 13-HH, 14-HH), 1.68–1.49 (m, 7 H, 4-
HH, 5-HH, 7-H, 8-HH, 12-H2, 13-HH), 1.43–1.33 (m, 2 H, 3-HH, 4-HH);
13C NMR (MeOD, 125 MHz): δ=68.7 (C-11), 68.1 (C-6), 58.9 (C-2),
56.4 (C-10), 55.4 (C-14), 53.7 (C-16), 37.3 (C-8), 36.5 (C-7), 33.2 (C-9),
31.4 (C-4), 27.8 (C-12), 26.1 (C-3), 26.0 (C-5), 21.6 (C-13) ppm; IR
(ATR): ~v =2928, 2857, 2755, 2719, 1463, 1442, 1332, 1279, 1117,
1102, 1064, 1042, 802, 734 cm  1; HRMS (ESI): m/z calcd for C14H24N2
+H+ : 221.20123 [M+H]+; found: 221.20081.
Pyrrolocytisine 23: The reaction sequence 20!23 was performed
in analogy to the sequence 7!21!22 described above. Treatment
of a solution of the N-Boc imide 20 (101 mg, 332 μmol) in anhydr.
THF (3 mL) with 17 (0.29 M in THF, 3.43 mL, 996 μmol), prepared
from 3-bromo-1,1-dimethoxypropane (299 μL, 406 mg, 2.22 mmol)
and Mg (49.0 mg, 2.02 mmol) in anhydr. THF (7 mL), afforded, after
aqueous work up, the crude addition product (158 mg), which was
directly subjected to deprotection and cyclization by treatment
with BF3*OEt2 (210 μL, 230 mg, 1.66 mmol) in anhydr. CH2Cl2 (5 mL).
After work up and column chromatography (SiO2, CH2Cl2/MeOH/
NH3 (aq., 25%) 100 :0 : 0!95 :4.5 : 0.5), the pyrrolocytisine 23 was
obtained as a colorless resin; yield: 34.9 mg (154 μmol, 46%); Rf =
0.48 (CH2Cl2/MeOH/NH3 (aq., 25%) 97 :2.7 : 0.3); [α]D
25=   192.0 (c=
0.5, MeOH); 1H NMR (CDCl3, 500 MHz): δ=7.24 (dd, J =9.0 Hz,
6.9 Hz, 1 H, 4-H), 6.55 (dd, J =2.4 Hz, 1.7 Hz, 1 H, 13-H), 6.38 (dd, J =
9.0 Hz, 1.1 Hz, 1 H, 3-H), 6.10 (m, 2 H, 5-H, 14-H), 5.94 (dd, J =3.4 Hz,
1.6 Hz, 1 H, 15-H), 4.30 (dd, J =16.1 Hz, 8.4 Hz, 1 H, 10-HH), 4.21 (dd,
J =12.4 Hz, 4.5 Hz, 1 H, 11-HH), 4.12 (s, 1 H, 7-H), 4.07 (d, J =12.4 Hz,
1 H, 11-HH), 3.95 (d, J =16.1 Hz, 1 H, 10-HH), 2.95 (m, 1 H, 9-H), 2.21
(dm, J =12.9 Hz, 1 H, 8-HH), 2.14 (dm, J =12.9 Hz, 1 H, 8-HH); 13C
NMR (CDCl3, 125 MHz): δ=163.6 (C-2), 149.9 (C-6), 139.4 (C-4), 129.2
(C-16), 120.1 (C-13), 117.2 (C-3), 109.0 (C-14), 105.0 (C-15), 104.0 (C-
5), 52.1 (C-11), 48.5 (C-10), 34.1 (C-7), 26.4 (C-9), 24.2 (C-8) ppm; IR
(ATR): ~v =2935, 1653, 1572, 1542, 1494, 1280, 1142, 1053, 803, 749,
721 cm  1; HRMS (ESI): m/z calcd for C14H14N2O+H
+ : 227.11845 [M+
H]+; found: 227.11812.
Isoleontidine (24): Following the general hydrogenation procedure,
pyrrole 23 (40.9 mg, 181 μmol) was hydrogenated for 3.5 h. Work
up and chromatography afforded the non-natural alkaloid isoleonti-
dine (24) as a colorless resin; yield: 24.2 mg (105 μmol, 58%); Rf =
0.31 (CH2Cl2/MeOH 95 :5); [α]D
25=   186.6 (c =0.5, MeOH); 1H NMR
(CDCl3, 500 MHz): δ=7.25 (dd, J =8.9 Hz, 7.0 Hz, 1 H, 4-H), 6.44 (d,
J =8.3 Hz, 1 H, 3-H), 5.83 (d, J =6.5 Hz, 1 H, 5-H), 3.97 (d, J =15.4 Hz,
1 H, 10-HH), 3.88 (dd, J =15.4 Hz, 7.0 Hz, 1 H, 10-HH), 3.08 (d, J =
10.4 Hz, 1 H, 11-HH), 2.87 (m, 2 H, 7-H, 13-HH), 2.44 (s, 1 H, 9-H),
2.28 (d, J =10.5 Hz, 1 H, 11-HH), 2.09 (m, 1 H, 16-H), 2.00 (m, 2 H, 8-
HH, 13-HH), 1.78 (m, 1 H, 8-HH), 1.66 (m, 1 H, 15-HH), 1.55 (m, 2 H,
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14-H2), 1.44 (m, 1 H, 15-HH);
13C NMR (CDCl3, 125 MHz): δ=164.1 (C-
2), 147.7 (C-6), 137.7 (C-4), 117.0 (C-3), 107.7 (C-5), 67.3 (C-16), 59.4
(C-11), 53.7 (C-13), 50.6 (C-10), 37.6 (C-7), 28.0 (C-9), 27.3 (C-8), 27.0
(C-15), 20.6 (C-14) ppm; IR (ATR): ~v =2932, 2782, 1651, 1568, 1547,
1367, 1347, 1142, 800 cm  1; HRMS (ESI): m/z calcd for C14H18N2O+
H+ : 231.14919 [M+H]+; found: 231.14881.
N-Boc-11-methoxycytisine (25): According to ref. [12], a solution of
the N-Boc imide 15 (307 mg, 1.01 mmol) in anhydr. MeOH (30 mL)
was treated with NaBH4 (114 mg, 3.03 mmol) at 0 °C and stirred for
90 min at this temperature. Methanolic HCl (2.0 M; 2.83 mL) was
added and the reaction mixture was allowed to reach rt over 4 h.
Sat. aq. NaHCO3 (20 mL) was added and the solvent was removed
under vacuum. The aqueous layer was extracted with CH2Cl2 (5×
25 mL) and the combined organic layers were dried over Na2SO4.
Column chromatography (SiO2, CH2Cl2/MeOH 100 :0!95 :5) deliv-
ered the N,O-acetal 25 as a colorless resin; yield: 295 mg (921 μmol,
91%; ref. [12]: 90%). All characterization data were in full agree-
ment with those reported in ref. [12].
11-Allylcytisine (26): According to ref. [12], allyltrimethylsilane
(390 μL, 281 mg, 2.46 mmol) and BF3 ·OEt2 (156 μL, 175 mg,
1.23 mmol) were added at 0 °C to a solution of the N,O-acetal 25
(132 mg, 410 μmol) in anhydr. CH2Cl2 (6 mL). After 16 h at rt, the
crude mixture was adsorbed to a small amount of silica and
subjected to column chromatography (SiO2, CH2Cl2/MeOH/NH3 (aq.,
25%) 100 :0 : 0!90 :9.1 :0.9) to give 11-allylcytisine (26) as a white
solid; yield: 80.0 mg (347 μmol, 85%; ref. [12]: 93%). All character-
ization data were in full agreement with those reported in
refs. [10,12, 23a,23c,23d].
11-(3-Hydroxypropyl)cytisine (27): 9-BBN (0.5 M in THF, 1.21 mL,
605 μmol) was slowly added at 0 °C to a solution of 11-allylcytisine
(26; 69.5 mg, 302 μmol) in anhydr. THF (7 mL). The mixture was
refluxed for 5 h and cooled to rt. Aq. H2O2 (30 wt%, 7 mL,
68.5 mmol) and aq. NaOCl (5 wt% active Cl, 7 mL, 10.0 mmol) were
added and stirring was continued for 2 h. Aq. NaOH (6 M, 3.5 mL)
was added and the aqueous layer was extracted with CH2Cl2 (20×9
mL). The combined organic layers were dried over Na2SO4 and
concentrated under reduced pressure. The residue was purified by
column chromatography (SiO2, CH2Cl2/MeOH/NH3 (aq., 25%)
100 :0:0!90 :9 : 1), providing the alcohol 27 as a colorless resin;
yield: 61.1 mg (246 μmol, 81%); Rf =0.14 (CH2Cl2/MeOH/NH3 (aq.,
25%) 95 :4.5 :0.5); [α]D
25=   74.0 (c=1.0, MeOH); 1H NMR (CDCl3,
500 MHz): δ=7.29 (dd, J =9.0 Hz, 6.9 Hz, 1 H, 4-H), 6.44 (dd, J =
9.0 Hz, 1.0 Hz, 1 H, 3-H), 5.99 (dd, J =6.8 Hz, 0.7 Hz, 1 H, 5-H), 4.14
(d, J =15.8 Hz, 1 H, 10-HH), 3.89 (dd, J =15.8 Hz, 6.5 Hz, 1 H, 10-HH),
3.68 (ddd, J =11.0 Hz, 5.5 Hz, 4.2 Hz, 1 H, CHHOH), 3.54 (ddd, J =
11.0 Hz, 8.0 Hz, 3.0 Hz, 1 H, CHHOH), 3.32 (br. s, 2 H, NH, OH), 3.26
(dd, J =13.4 Hz, 2.4 Hz, 1 H, 13-HH), 2.94 (d, J =10.1 Hz, 1 H, 11-H),
2.86 (s, 1 H, 7-H), 2.75 (dt, J =13.4 Hz, 2.1 Hz, 1 H, 13-HH), 2.22 (d,
J =2.5 Hz, 1 H, 9-H), 2.15 (d, J =13.3 Hz, 1 H, 8-HH), 1.99 (m, 1 H,
CHH(CH2)2OH), 1.89–1.74 (m, 2 H, 8-HH, CHHCH2OH), 1.69–1.54 (m, 2
H, CHH(CH2)2OH, CHHCH2OH);
13C NMR (CDCl3, 125 MHz): δ=163.7
(C-2), 150.5 (C-6), 139.2 (C-4), 117.1 (C-3), 105.2 (C-5), 62.9 (CH2OH),
59.4 (C-11), 51.1 (C-10), 47.3 (C-13), 35.2 (C-7), 32.0 (C-9), 31.6
(CH2CH2OH), 29.5 (CH2(CH2)2OH), 21.3 (C-8) ppm; IR (ATR): ~v =2932,
2236, 1645, 1544, 1356, 1144, 1059, 909, 796, 723 cm  1; HRMS (ESI):
m/z calcd for C14H20N2O2+H
+ : 249.15975 [M+H]+; found:
249.15971.
Camoensine (10): A solution of the alcohol 27 (112 mg, 451 μmol)
in anhydr. CH2Cl2 (5 mL) was treated at 0 °C with CBr4 (329 mg, 992
μmol), NEt3 (81.3 μL, 59.3 mg, 586 μmol), and PPh3 (213 mg, 812
μmol). After 18 h at rt, the reaction mixture was quenched with aq.
HCl (0.5 M, 7 mL). The organic layer was separated and the aqueous
layer was extracted with CH2Cl2 (7 mL). The organic layers were
discarded. The aqueous layer was basified (pH=14) with aq. NaOH
(6.0 M; 3 mL) and extracted with CH2Cl2 (5×12 mL). The organic
layers were combined and dried over Na2SO. Removal of the
solvent under vacuum and column chromatography (deactivated
SiO2, CH2Cl2/MeOH/NH3 (aq., 25%) 98 :1.8 : 0.2!90 :9.1 : 0.9) afforded
the natural alkaloid camoensine (10) as a colorless oil; yield:
87.4 mg (379 μmol, 84%); Rf =0.23 (CH2Cl2/MeOH/NH3 (aq., 25%)
95 :4.5 : 0.5); [α]D
24=   113.1 (c=0.5, CHCl3) {ref. [10]: [α]D
20=   112.9
(c =0.5, CHCl3); ref. [4e]: [α]D=   108 (c =1.0, CHCl3); ref. [6g]: [α]D=
  186}[29]; 1H NMR (CDCl3, 500 MHz): δ=7.27 (dd, J =9.0 Hz, 7.0 Hz, 1
H, 4-H), 6.42 (d, J =9.0 Hz, 1 H, 3-H), 6.00 (d, J =6.6 Hz, 1 H, 5-H),
4.17 (d, J =15.3 Hz, 1 H, 10-HH), 3.88 (dd, J =15.3 Hz, 6.2 Hz, 1 H,
10-HH), 2.99 (tm, J =8.7 Hz, 1 H, 11-H), 2.92 (s,1 H, 7-H), 2.75–2.63
(m, 4 H, 14-H2, 16-H2), 2.48 (s, 1 H, 9-H), 2.00–1.87 (m, 2 H, 8-HH, 13-
HH), 1.83–1.60 (m, 4 H, 8-HH, 12-H2, 13-HH);
13C NMR (CDCl3,
125 MHz): δ=163.7 (C-2), 150.9 (C-6), 138.9 (C-4), 116.9 (C-3), 105.0
(C-5), 66.1 (C-11), 55.0 (C-14 or C-16), 54.9 (C-14 or C-16), 51.8 (C-
10), 35.0 (C-7), 29.0 (C-9), 25.2 (C-12), 21.3 (C-13), 20.8 (C-8) ppm; IR
(ATR): ~v =2949, 2873, 1648, 1565, 1547, 1163, 1142, 800, 734 cm  1;
HRMS (ESI): m/z calcd for C14H18N2O+H
+ : 231.14919 [M+H]+;
found: 231.14842. The 13C NMR data are in full agreement with
those reported for synthetic 10 in ref. [10]. For a detailed
comparison of our NMR data with literature NMR data of isolated
10,[4e,6g] see Supporting Information.
Camoensidine (11): Following the general hydrogenation proce-
dure, camoensine (10, 90.7 mg, 394 μmol) was hydrogenated for
15 h. Work up and chromatography (deactivated SiO2) delivered the
natural alkaloid camoensidine (11) as a pale yellow oil; yield:
73.1 mg (312 μmol, 79%); Rf =0.27 (CH2Cl2/MeOH/NH3 (aq., 25%)
90 :9 : 1); [α]D
27=   72.5 (c =1.13, EtOH) {ref. [6g]: [α]D=   67; ref. [4a]:
[α]D
27=   73 (c =1.13, EtOH)}; 1H NMR (CDCl3, 500 MHz): δ=4.57 (d,
J =13.1 Hz, 1 H, 10-HH), 3.34 (t, J =7.0 Hz, 1 H, 6-H), 2.73 (m, 2 H,
14-HH, 16-HH), 2.63 (d, J =13.1 Hz, 1 H, 10-HH), 2.43–2.20 (m, 5 H, 3-
H2, 11-H, 14-HH, 16-HH), 2.02 (m, 1 H, 5-HH), 1.94 (s, 1 H, 9-H), 1.85–
1.68 (m, 6 H, 4-HH, 7-H, 8-HH, 12-H2, 13-HH), 1.63–1.45 (m, 3 H, 4-
HH, 8-HH, 13-HH), 1.35 (d, J =12.5 Hz, 1 H, 5-HH); 13C NMR (CDCl3,
125 MHz): δ=171.4 (C-2), 64.6 (C-11), 60.1 (C-6), 54.5 (C-14), 49.4 (C-
16), 47.6 (C-10), 33.2 (C-3), 33.2 (C-7), 31.2 (C-9), 28.9 (C-8), 27.6 (C-
12), 27.6 (C-5), 21.1 (C-4), 20.1 (C-13) ppm; IR (ATR): ~v =2945, 2866,
1619, 1442, 1253, 1163, 1018, 916, 726, 641 cm  1; HRMS (ESI): m/z
calcd for C14H22N2O+H
+ : 235.18049 [M+H]+; found: 235.18016. For
a detailed comparison of our NMR data with literature NMR data of
isolated 11,[4a,e] see Supporting Information.
11-Epileontidane (12): Camoensidine (11; 62.7 mg, 268 μmol) was
dissolved in anhydr. THF (4 mL) and cooled to 0 °C. LiAlH4 (2.4 M in
THF, 893 μL, 2.14 mmol) was added and the reaction mixture was
refluxed for 23 h. At rt, sat. aq. Na2SO4 (8 mL) was added dropwise
until gas evolution ceased. The aqueous layer was extracted with
Et2O (5×8 mL), and the combined organic layers were dried over
Na2SO4 and concentrated under reduced pressure. The residue was
dissolved in aq. HCl (1 M, 15 mL) and extracted with hexanes
(15 mL) and Et2O (15 mL). The organic layers were discarded. The
aqueous layer was basified (pH=14) with aq. NaOH (6.0 M, 15 mL)
and extracted with Et2O (3×15 mL). The combined organic layers
were dried over Na2SO4 and the solvent was removed under
vacuum to give the natural alkaloid 11-epileontidane (12) as a pale
yellow oil (note: this compound slowly decomposes upon exposure
to air); yield: 39.4 mg (179 μmol, 67%); Rf =0.23 (CH2Cl2/MeOH/NH3
(aq., 25%) 90 :9 : 1); [α]D
25= +23.2 (c =1.0, MeOH); 1H NMR (MeOD,
500 MHz): δ=2.87 (m, 1 H, 6-H), 2.84–2.70 (m, 4 H, 2-HH, 10-HH, 14-
HH, 16-HH), 2.64 (m, 2 H, 2-HH, 10-HH), 2.24 (dd, J =10.9 Hz, 2.4 Hz,
1 H, 16-HH), 1.98–1.86 (m, 5 H, 5-HH, 7-H, 11-H, 13-HH, 14-HH), 1.79
(m, 2 H, 3-HH, 4-HH), 1.68 (m, 3 H, 3-HH, 8-HH, 13-HH), 1.63–1.51 (m,
3 H, 8-HH, 9-H, 12-HH), 1.39–1.28 (m, 3 H, 4-HH, 5-HH, 12-HH); 13C
NMR (MeOD, 125 MHz): δ=67.4 (C-11), 65.9 (C-6), 63.5 (C-16), 58.1
(C-14), 55.4 (C-2), 50.6 (C-10), 35.8 (C-9), 33.6 (C-7), 31.1 (C-12), 29.6
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(C-3), 29.1 (C-5), 26.4 (C-8), 26.0 (C-13), 22.1 (C-4) ppm; IR (ATR): ~v =
2931, 2758, 1442, 1347, 1265, 1142, 1116, 1072 cm  1; HRMS (ESI):
m/z calcd for C14H24N2+H
+ : 221.20123 [M+H]+; found: 221.20079.
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